Pin1 inhibitors (Pinteon Therapeutics)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug NamePin1 inhibitors (Pinteon Therapeutics)
Drug Alias NameATRA derivatives (Beth Israel Deaconess Medical Center)Pin1 inhibitors (Beth Israel Deaconess Medical Center)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPeptidy-1-prolyl isomerase inhibitors
TargetsPeptidy-1-prolyl isomerase
Therapy Area/IndicationsAutoimmune DiseasesNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBeth Israel Deaconess Medical Center
China Registration ClassN/A

Develop Information

Active CompaniesPinteon Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsAutoimmune DiseasesNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A